VolitionRX Ltd (VNRX)

Dec 22, 2024

VolitionRx (NYSE:VNRX) Coverage Initiated at StockNews.com - Defense World

Dec 22, 2024

Dec 14, 2024

StockNews.com Begins Coverage on VolitionRx (NYSE:VNRX) - Defense World

Dec 14, 2024

Dec 11, 2024

VolitionRx CEO Cameron John Reynolds acquires $79,999 in stock By Investing.com - Investing.com Nigeria

Dec 11, 2024

Dec 10, 2024

Volitionrx director Innes buys $99,999 in common stock By Investing.com - Investing.com Australia

Dec 10, 2024

Dec 10, 2024

Volitionrx director Innes buys $99,999 in common stock - Investing.com India

Dec 10, 2024

Dec 10, 2024

VolitionRx chief scientific officer Micallef acquires $24,999 in stock By Investing.com - Investing.com Australia

Dec 10, 2024

Dec 10, 2024

VolitionRx CEO Cameron John Reynolds acquires $79,999 in stock - Investing.com

Dec 10, 2024

Dec 09, 2024

SEC Form 424B5 filed by VolitionRX Limited - Quantisnow

Dec 09, 2024

Dec 09, 2024

Form 424B5 VOLITIONRX LTD - StreetInsider.com

Dec 09, 2024

Dec 06, 2024

VolitionRx announces $1.9 million stock sale By Investing.com - Investing.com Australia

Dec 06, 2024

Dec 06, 2024

VolitionRx Secures $1.9M Financing with Insider Backing, Includes Strategic Warrant Package - StockTitan

Dec 06, 2024

Dec 04, 2024

VNRX: VolitionRx Reports 3Q 2024 results. Over 110,000 Nu.Q Canine Cancer tests have been sold. Cost cutting continues in a plan to be cash flow neutral in 2025. Management focused on signing licensing deals for Capture-PCR & Nu.Q NETs. - Zacks Small Cap Research

Dec 04, 2024

Dec 02, 2024

VolitionRx: Big EU Trials On Deck - Investing.com

Dec 02, 2024

Nov 28, 2024

VolitionRx (NYSE:VNRX) Coverage Initiated by Analysts at StockNews.com - Defense World

Nov 28, 2024

Nov 23, 2024

Benchmark Reaffirms Hold Rating for VolitionRx (NYSE:VNRX) - MarketBeat

Nov 23, 2024

Nov 20, 2024

VolitionRx Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 20, 2024

Nov 16, 2024

VolitionRx Limited (AMEX:VNRX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 16, 2024

Nov 16, 2024

VolitionRX: Q3 Earnings Snapshot - New Haven Register

Nov 16, 2024

Nov 16, 2024

VolitionRX Ltd (VNRX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance

Nov 16, 2024

Nov 15, 2024

VolitionRx Posts Strong Q3 Growth and Strategic Advances - TipRanks

Nov 15, 2024

Nov 15, 2024

Lagoda Investment Management's Strategic Acquisition in Volition - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Armistice Capital, LLC Acquires New Stake in VolitionRX Ltd - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

VolitionRX Ltd Reports Q3 Revenue of $475,000, Missing Estimates of $0.65 Million - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

VolitionRX Ltd (VNRX) Q3 2024 Earnings Report Preview: What to L - GuruFocus.com

Nov 14, 2024

Nov 08, 2024

VolitionRx (VNRX) Sets Q3 2024 Earnings Call: Key Executives to Present Financial Results | VNRX Stock News - StockTitan

Nov 08, 2024

Nov 06, 2024

Volition Appoints Timothy I. Still as Chairman – Company Announcement - Financial Times

Nov 06, 2024

Nov 04, 2024

VolitionRx (NYSE:VNRX) Now Covered by StockNews.com - Defense World

Nov 04, 2024

Oct 31, 2024

Abionic’s test enters increasingly competitive sepsis fray - BioWorld Online

Oct 31, 2024

Oct 27, 2024

VolitionRx (NYSE:VNRX) Now Covered by Analysts at StockNews.com - Defense World

Oct 27, 2024

Oct 09, 2024

Volition to share new 'NETs in sepsis management' data insights at upcoming webinar - Quantisnow

Oct 09, 2024

Sep 30, 2024

VolitionRx adds Dr. Ethel Rubin to its board By Investing.com - Investing.com South Africa

Sep 30, 2024

Sep 30, 2024

VolitionRx adds Dr. Ethel Rubin to its board - Investing.com India

Sep 30, 2024

Sep 30, 2024

Volition Appoints Dr. Ethel Rubin as an Independent Director - Quantisnow

Sep 30, 2024

Sep 30, 2024

Volition Appoints Dr. Ethel Rubin as an Independent Director – Company Announcement - Financial Times

Sep 30, 2024

Sep 27, 2024

VolitionRx announces executive employment updates - Investing.com India

Sep 27, 2024

Sep 18, 2024

Agency News | ⚡Tamil Nadu’s Veterinary Varsity Directed by High Court To Consider Transgender Student’s Application - LatestLY

Sep 18, 2024

Sep 18, 2024

Madras HC directs TN veterinary varsity to not reject transgender's application over identity - Hindustan Times

Sep 18, 2024

Sep 18, 2024

Madras High Court Orders TN Veterinary University to Accept Transgender Candidate's Application - Law Trend

Sep 18, 2024

Sep 18, 2024

Don't reject transgender's application over identity HC tells TN veterinary varsity - The Week

Sep 18, 2024

Sep 18, 2024

Madras High Court Upholds Transgender Rights for Veterinary Course Admissions - Devdiscourse

Sep 18, 2024

Sep 17, 2024

Volato Facing Class-action WARN Act Lawsuit - Aviation International News

Sep 17, 2024

Sep 17, 2024

VolitionRx offers oncology assets for licensing - Investing.com India

Sep 17, 2024

Sep 17, 2024

VolitionRx offers oncology assets for licensing By Investing.com - Investing.com Australia

Sep 17, 2024

Sep 16, 2024

Volition Announces Board of Directors - TechBuzz News

Sep 16, 2024

Sep 14, 2024

CRYPTOPSY's New Shirts Are Very Serious - Metal Injection

Sep 14, 2024

Sep 13, 2024

Terminated Volato Employees File Class Action Lawsuit - FLYING

Sep 13, 2024

Sep 12, 2024

LifeLabs workers in GTA poised to strike if deal not reached by Saturday - CP24

Sep 12, 2024